227 related articles for article (PubMed ID: 2189619)
21. ACE inhibitors versus diuretics: when to choose which drug?
Sharpe N
Cardiovasc Drugs Ther; 1993 Dec; 7(6):877-9. PubMed ID: 8011562
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin antagonism in patients with heart failure: ACE inhibitors, angiotensin receptor antagonists or both?
Cruden NL; Newby DE
Am J Cardiovasc Drugs; 2004; 4(6):345-53. PubMed ID: 15554719
[TBL] [Abstract][Full Text] [Related]
23. Lessons from recent randomized controlled trials for the management of congestive heart failure.
Riegger GA
Am J Cardiol; 1993 Jun; 71(17):38E-40E. PubMed ID: 8328366
[TBL] [Abstract][Full Text] [Related]
24. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
[TBL] [Abstract][Full Text] [Related]
25. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
26. [Indications for ACE inhibitors in chronic heart failure].
Erdmann E
Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE; McKinnie JJ; Greenberg SS; Giles TD
Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
[TBL] [Abstract][Full Text] [Related]
28. [Progress in management for heart failure: diuretics].
Aoyagi T; Hirata Y
Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795
[TBL] [Abstract][Full Text] [Related]
29. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
Kromer EP; Elsner D; Riegger GA
Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure.
Reyes AJ
Am J Cardiol; 1995 Jun; 75(18):50F-55F. PubMed ID: 7778535
[TBL] [Abstract][Full Text] [Related]
31. Fundamental role of angiotensin-converting enzyme inhibitors in the management of congestive heart failure.
Opie LH
Am J Cardiol; 1995 Jun; 75(18):3F-6F. PubMed ID: 7778532
[TBL] [Abstract][Full Text] [Related]
32. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitors in congestive heart failure.
Deedwania PC
Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
[TBL] [Abstract][Full Text] [Related]
34. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
35. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
Martineau P; Goulet J
Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
[TBL] [Abstract][Full Text] [Related]
36. [Drug treatment for chronic heart failure with reduced ejection fraction].
Rickenbacher P
Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
[TBL] [Abstract][Full Text] [Related]
37. Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure.
Munger MA
Ann Pharmacother; 1993 Feb; 27(2):205-10. PubMed ID: 8439700
[TBL] [Abstract][Full Text] [Related]
38. Refocus on diuretics in the treatment of heart failure.
Taylor SH
Eur Heart J; 1995 Jul; 16 Suppl F():7-15. PubMed ID: 8521885
[TBL] [Abstract][Full Text] [Related]
39. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin converting enzyme inhibitors and moderate hypertension.
McAreavey D; Robertson JI
Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
